Autism Bio Med Center


Autism Spectrum Disorder (ASD) is a behavioral/developmental disorder characterized clinically by delays and qualitative differences in communication and social interactions well as repetitive behaviors and restricted interests. Currently, it is a subjective psychiatric diagnosis based on behaviors exhibited in the child rather than an objective medical diagnosis based on core clinical imbalances resulting in abnormal behaviors. This subtle but powerful difference in diagnosing patients with autism has resulted in profound effects on the results of medical trials. Many trials have been plagued with inconsistent results because patients are being selected based on the behaviors they exhibit rather than known clinical imbalances they possess which cause or contribute to the behaviors.

There is no single cause of autism. Instead, the causes are as varied and diverse as the individuals who are affected. This is the primary reason why the pharmaceutical industry has failed to produce any effective treatments beyond simple symptom control (such as antipsychotics for agitation or stimulants for inattention).

autism-las-vegasYour child’s conventional medical doctor has probably done very little for your child because they have been trained that there is no cure for autism and your child’s symptoms and behaviors are a result of their autism. The diagnosis of autism in your child was made subjectively, based on the symptoms and behaviors they exhibited. This reasoning dictates that the symptoms define the disease (behaviors therefore autism) and the disease causes the symptoms (autism therefore behaviors). This is a logical fallacy called circular cause and consequenceWith this illogical thinking, its no wonder conventional medicine has almost nothing to offer our children with autism. Autism is not an entity which bites your child and then causes disease – it is just a convenient name to place individuals exhibiting similar behaviors stemming from a multitude of different physiological insults and imbalances. Language may guide thought, but names do not cause disease.

Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD)

From a functional medicine perspective, there is much overlap between these two disorders. Both are neurodevelopmental disorders, both can be functionally debilitating for the affected individual and both can be greatly improved, or even overcome, with the correct balancing of systems and appropriate neurological stimulation (various therapies).
Many of the biomedical approaches which are successful in ASD are also beneficial for ADHD. This is no coincidence because the root cause of both disorders is neurological dysfunction secondary to many of the clinical imbalances described below. The way the individual expresses this neurological dysfunction and how it impacts their daily functioning is usually a matter of severity. Typically, the level of neurological deficit is significantly less in individuals with ADHD compared ASD, typically resulting in a more rapid and dramatic response to treatment.

The Role of Genetics

dna-strandAbout 6-10% of patient with ASD have Syndromic Autism. Syndromic Autism is defined as autism secondary to an existing genetic syndrome such as Fragile X Syndrome, Down Syndrome or Duchenne’s muscular dystrophy, to name a few. For a more complete list of syndromes click here.
Many of the biochemical contributing factors may still be present in these patients, however the response to treatment may not be as successful as in Non-syndromic Autism.

Non-syndromic Autism comprises the vast majority of ASD individuals (90-94%). They have no definitive genetic cause for their autism. However, many of them will have genetic mutations which play a significant role in the contributing factors listed below (i.e. MTHFR, FOLR1, DHFR, GSTM1 etc.)

Over the past decade, conventional medicine has directed much of its research efforts and funding towards identifying the gene or genes responsible for autism. Billions of dollars have been spent with no substantial changes in the proportion of patients identified with a clear-cut genetic cause. This misdirection of research resources has resulted in a grave disservice to our children with autism. Future generations of children with autism may possibly benefit from this research but the current generation is being marginalized by resource allocation decisions of our current conventional medical model. Treatments are available for our kids today. With the availability of adequate research dollars, these treatments could be refined and improved at a much quicker pace than is happening today.

Our Approach

The Autism Biomed Center program is based on the foundational principles of Functional Medicine and protocols developed by the faculty of the Medical Academy of Pediatric Special Needs


Our approach asks two keys questions:
1. Is the patient’s body and brain getting what they need to function optimally (i.e. vitamins, minerals, omega-3 fatty acids, healthy clean food, etc.)?
Ensure the good stuff gets in.

2. Is something present in the patient’s body and brain that is interfering with their ability to function optimally (i.e. toxins, low grade infection, disrupted microbiome, free radicals, cytokines, histamine etc.)?
Ensure the bad stuff gets out.

In the context of these two questions, causes and contributing factors leading to clinical imbalances are identified and corrected.
We do not accept the conventional thinking that autism is an entity onto itself causing disease in the individual. Instead, autism is viewed only as a label for a group of individuals who share similar abnormalities in development and behaviors. By providing the body and brain with what they need and eliminating that which may be interfering, the potential exists to significantly improve brain function and improve the quality of life for these individuals.

This approach to medical practice allows us to offer gentle and supportive therapies to restore balance and allow the body’s natural healing ability to become our partner in achieving optimal health and wellness.

Autism Spectrum Disorder Causes and Contributing Factors

A large and rapidly growing body of research points towards ASD as an underlying genetic vulnerability which is then activated by environmental triggers. The combination of these two components then become the causes and/or contributing factors which we connect to the patient’s existing psychiatric diagnosis of ASD. There are a myriad of biomedical factors affecting the brain function of patients with autism. Most common contributing factors are listed below:

  • Nutrition – deficiencies (particularly zinc, magnesium, B vitamins, vitamin D, vitamin A, antioxidants and omega-3 fatty acids) or increased needs from genetic mutations in biochemical pathways or poor intestinal absorption
  • Food sensitivities/intolerances – particularly gluten and casein, which can produce opiate- like byproducts in susceptible patients
  • Altered intestinal permeability
  • Intestinal dysbiosis – pathological alterations in the gut microbiome
  • Impaired methylation/transsulfuration
  • Impaired detoxification
  • Chronic inflammation
  • Oxidative stress
  • Mitochondrial dysfunction
  • Autoimmunity or immune dysfunction
  • Impaired production of hormones and/or neurotransmitters

One or more of these factors are present in almost all individuals with autism. All of these factors are functionally interrelated and most patients will have multiple factors contributing to their autistic behaviors. Some patients have all of them.

  • food-colors2Nutrition: begins with intake, however there is more to this than diet alone. Nutrition is what an individual eats, absorbs and delivers to their cells. Problems may start at the very beginning of this pathway with restricted appetite, food choices and overall poor intake or at the very end with certain mutations affecting adequate absorption of nutrients into cells of the brain. Many biomedical factors must be assessed such as reflux, constipation and zinc deficiency resulting in poor taste perception. Disruptions in sensation which can affect the taste, texture, smell and sight of food are also common in autism. Ensuring nutrients are at adequate levels for the individual, not just bare minimum norms determined for the population as a whole, can help support more optimal functioning. Many individuals with autism present with a variety of nutrients at deficient or suboptimal levels. Blood tests and functional urine testing can help identify these deficits or inefficiencies.
    B Vitamins: unmet needs are common in autism. These vitamins play a critical role in human biochemistry by supporting energy metabolism, neurotransmitter synthesis, fat & protein metabolism, nerve function, brain health and overall health. Particularly B1, B2, B3, B6, B12 and folate.
    Vitamin A: antioxidant important in immune function and vision, including eye contact. Deficiency occurs in a subset of patients with autism.
    Vitamin D: deficiency is common in the general population as a whole. When present with autism, will exacerbate other clinical imbalances – particularly in relation to cognition and the immune system.
    Zinc: deficiencies are common in autism. This can be due to use of antacid medications, high glycemic diets, poor dietary intake of animal protein and the presence of toxic metals. Zinc is an essential cofactor in over 200 enzymatic reactions in the body which play roles in immune function, vitamin A transport, amino acid metabolism, toxic metal detoxification and taste perception.
    Magnesium: deficiency is common in the general population as whole and is seen even more in individuals with autism. Magnesium is an essential cofactor in over 300 enzymatic reactions in the body which play roles in energy (ATP) production, neurotransmitter function, methylation, transsulfuration and glutathione metabolism. Magnesium deficiency can result in many symptoms seen with autism, such as hyperactivity, anxiety, poor sleep and constipation.
    Omega-3 Fatty Acids: The Standard American Diet (SAD) provides excess pro-inflammatory omega-6 fatty acids and inadequate anti-inflammatory omega-3 fatty acids. Individuals with autism on a SAD can create a pro-inflammatory state in their bodies which could exacerbate other clinical imbalances. Omega-3 fatty acids, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have numerous health benefits.
  • Food sensitivities/intolerances: a significant number of individuals with autism are sensitive or intolerant of certain foods. While some may have traditional allergies (IgE mediated – what is tested at an allergist’s office), many more will have IgG mediated sensitivities which can result in physical, neurological and behavioral symptoms. IgG mediated food sensitivities differ from traditional food allergies in that they can occur in more delayed timeframe – up to 72 hours after ingestion of the sensitized food. IgG food sensitivity testing can give some indication of immunological reactions to food but the gold standard for diagnosis is an Elimination Diet. This consists of total elimination of the suspected offending food for several weeks followed by re-challenge with that food. Food sensitive individuals will have improvements with elimination of the food and worsening with reintroduction. Common food sensitivities seen in individuals with autism are casein (a dairy protein) and gluten (a protein found in wheat, barley and rye). Food sensitivity will typically affect brain function through altered intestinal permeability (also known as ‘leaky gut’). Offending foods can disrupt the membranes of the intestine allowing incompletely digested molecules to enter the bloodstream. Some of these undigested molecules are able to cross the blood-brain barrier and impact optimal brain function in many different ways including chronic inflammation, immune system dysregulation, opioid- like peptides and false neurotransmitters. A large number of individuals with autism exhibit food sensitivities. If the offending food or foods can be identified and eliminated, dramatic improvements usually follow.


  • Intestinal dysbiosis: an imbalance in the intestinal micro biomeA rapidly growing body of research is documenting the close interrelationship of intestinal function and brain health. The intestine is home to trillions of beneficial bacteria that serve many useful functions including immune system regulation, production of nutrients, reduction of inflammation, improved digestion and absorption, and inhibition of the growth of harmful microbes. The main risks for developing dysbiosis are antibiotic use and inadequate dietary fiber. Through probiotics, changes in diet and other methods, the microbiome can be rebalanced leading to positive, visible changes in brain health and intestinal function.
    • Impaired methylation/transsulfuration: the folate, methylation and sulfation cycles are interconnected biochemical pathways which serve vital functions in DNA synthesis, gene expression, neurotransmitter metabolism, antioxidant support and detoxification. These pathways are dependent on many vitamins and minerals, particularly folate, B12 and B6. These pathways often function poorly in individuals with autism. Measurement and correction of the imbalanced metabolites by appropriate supplementation is foundational to the successful biomedical treatment of autism.


    • Impaired detoxification: in some individuals detoxification can be decreased secondary to a physiological imbalance, genetic mutation or may be simply overwhelmed by the sheer number of toxins present in the modern environment. It may be caused by something as simple as constipation. In addition, many individuals with autism have impaired glutathione production. Glutathione is the body’s ultimate antioxidant and an essential factor for many detoxification processes within us. Deficiencies in the methylation/ transsulfuration cycle can adversely affect glutathione production and in the presence of these deficiencies, toxins may not be eliminated efficiently resulting in negative consequences on brain functioning, mitochondrial health and overall increases in oxidative stress and inflammation. These individuals will require assistance for optimal detoxification. Detoxification is a subject largely ignored in medical school, but there are many techniques available to remove toxins from the body, including oral and intravenous therapies.


    • Mitochondrial dysfunction: mitochondria are within all cells of the body and are responsible for almost all of our energy production. Whereas a small subset of individuals with autism have outright mitochondrial disease, a much larger number have mitochondrial dysfunction. The difference between disease and dysfunction is in severity along a spectrum, much the same as autism. Mitochondrial dysfunction may be secondary to insufficient nutrients needed for optimal enzyme function or an inability of the individual to synthesize certain factors. Given their vital role in energy production, contributing factor can have far-reaching effects on overall health. Mitochondrial dysfunction can be managed and even reversed with nutritional support (supplements and targeted food plans), lifestyle modification (specific types of exercise, meal-timing & adequate sleep) and individualized neuro-rehabilitative techniques.


    • Oxidative stress and inflammation: oxidative stress is a process which the body responds to stressors (i.e infection, toxins, trauma etc.) via the production of free radicals. The free radicals attack the stressor only when the system is in balance. When imbalanced, those same free radicals can result in damage to healthy cells and DNA. Imbalances may occur from a variety of reasons, the most common being chronic inflammation and insufficient levels of antioxidants. The negative effects of oxidative stress have been observed on the functioning of brain glial cells. Glial cells provide nourishment to neurons and clean up toxic byproducts. When glial cell function is poor, negative effects are noted on brain function. Poor language, poor sensory processing and overall suboptimal brain function has been noted when these imbalances persist. Most of the other contributing factors directly or indirectly result in oxidative stress and correction of this imbalance is crucial. Finding the root cause and reversing excess oxidative stress is one of the first steps in the biomedical management of autism.


  • Autoimmunity or immune dysfunction: a variety of immune system dysfunctions has been documented in autistic individuals. Increases in pro-inflammatory cytokines, decreases in natural killer cell activation, abnormal levels of immunoglobulin and brain autoantibodies have all been found in the brains of individuals with autism. This is one of the newest areas of research in treatment of autism and our knowledge of the imbalances in these areas is rapidly growing.
  • Imbalanced hormones/neurotransmitters: there is a huge diversity of these imbalances between different individuals with autism. Many can be corrected by balancing other issues (such as food sensitivities, methylation, immune dysfunction etc.) whereas others may require direct supplementation (such as oxytocin which is also known as “the bonding hormone” or “love hormone”).



The Autism Biomed Center approach is science-based and all the information presented here has been drawn from various peer-reviewed scientific literature cited below.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition (DSM-V). Arlington, VA: American Psychiatric Publishing; 2013.Prevalence of autism spectrum disorders: autism and developmental disabilities monitoring network, 14 sites, United States, 2008. MMWR. http://www. Accessed October 10, 2013.

Compart, PJ. The pathophysiology of autism. Global Adv Health Med. 2013;2(6):32-37. doi: 10.7453/ gahmj.2013.092

Baker, SM. Learning about autism. Global Adv Health Med. 2013;2(6):38-46. doi: 10.7453/ gahmj. 2013.068

Frye RE, Rossignol DA. Treatments for biomedical abnormalities associated with autism spectrum disorder. Front Pediatr (2014) 2:66. doi:10.3389/fped. 2014.00066

Ecker C, Spooren W, Murphy DG. Translational approaches to the biology of autism: false dawn or a new era? Mol Psychiatry (2013) 18(4):435–42. doi:10.1038/mp.2012.102

Rossignol DA, Frye RE. A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol Psychiatry (2012) 17:389–401. doi:10.1038/mp.2011.165 Volkmar FR, McPartland JC. From Kanner to DSM-5: autism as an evolving diagnostic concept. Annu Rev Clin Psychol (2013) 10:193–212. doi:10.1146/ annurev- clinpsy- 032813- 153710

James SJ, Melnyk S, Jernigan S, et al. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet. 2006;141B(8): 947-56.

Walker, SJ, Fortunato J, Gonzalez LG, Krigsman A. Identification of a unique gene expression profile in children with regressive autism spectrum disorder (ASD) and ileocolitis. PLoS One. 2013;8(3):e58058.

Neale BM, Kou Y, Liu L, Ma’ayan A, Samocha KE, Sabo A, et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature (2012) 485:242–5. doi:10.1038/nature11011

Sanders SJ, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ, Willsey AJ, et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature (2012) 485:237–41. doi:10.1038/nature10945

Napoli E, Dueñas N, Giulivi C. Potential therapeutic use of the ketogenic diet in autism spectrum disorders. Front Pediatr (2014) 2:69. doi:10.3389/fped.2014. 00069

Adams JB, Audhya T, McDonough-Means S, et al. Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity. Nutr Metab (Lond). 2011;8(1):34.

Kaluzna-Czaplinska J. Noninvasive urinary organic acids test to assess bio- chemical and nutritional individuality in autistic children. Clin Biochem. 2011;44(8-9):686-91.

Mousain-Bosc M, Roche M, Polge A, Pradal-Prat D, Rapin J, Bali JP. Improvement in neurobehavioral disorders in children supplemented with magnesium-vitamin B6. II. Pervasive developmental disorder- autism. Magnes Res. 2006;19(1):53-62.

Kočovská E, Fernell E, Billstedt E, Minnis H, Gillberg C. Vitamin D and autism: clinical review. Res Dev Disabil. 2012;33(5):1541-50.

Mostafa GA, Al-Ayadhi LY. Reduced serum concentrations of 25-hydroxy vitamin D in children with autism: relation to autoimmunity. J Neuroinflammation. 2012 Aug 17;9:201.

Bjorklund G. The role of zinc and copper in autism spectrum disorders. Acta Neurobiol Exp (Wars). 2013;73(2):225-36.

Herbert MR, Buckley JA. Autism and dietary therapy: case report and review of the literature. J Child Neurol. 2013;28(8):975-82.

Schaevitz LR, Berger-Sweeney JE. Gene-environment interactions and epigenetic pathways in autism: the importance of one-carbon metabolism. ILAR J. 2012;53(3-4):322-40.

Pu D, Shen Y, Wu J. Association between MTHFR gene polymorphisms and the risk of autism spectrum disorders: a meta-analysis. Autism Res. 2013 May 7. doi: 10.1002/aur.1300.

Paşca SP, Dronca E, Kaucsár T, et al. One carbon metabolism disturbances and the C677T MTHFR gene polymorphism in children with autism spectrum disorders. J Cell Mol Med. 2009;13(10):4229-38.

Frye RE, Sequeira JM, Quadros EV, James SJ, Rossignol DA. Cerebral folate receptor autoantibodies in autism spectrum disorder. Mol Psychiatry. 2013;18(3):369-81.

Ramaekers VT, Blau N, Sequeira JM, Nassogne MC, Quadros EV. Folate receptor autoimmunity and cerebral folate deficiency in low-functioning autism with neurological deficits. Neuropediatrics. 2007;38(6): 276-81.

Raemaekers VT, Sequeira JM, Blau N, Quadros EV. A milk-free diet downregulates folate receptor autoimmunity in cerebral folate deficiency syndrome. Dev Med Child Neurol. 2008;50(5):346-52.

James SJ, Cutler P, Melnyk S, et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr. 2004;80(6):1611-17.

Frye RE, James SJ. Metabolic pathology of autism in relation to redox metabolism. Biomark Med (2014) 8:321–30. doi:10.2217/bmm.13.158

Melnyk S, Fuchs GJ, Schulz E, et al. Metabolic imbalance associated with methylation dysregulation and oxidative damage in children with autism. J Autism Dev Disord. 2012; 42(3):367-77.

James SJ, Melnyk S, Fuchs G, et al. Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism. Am J Clin Nutr. 2009;89(1):425-30.

James SJ, Rose S, Melnyk S, et al. Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism. FASEB J. 2009;23(8):2374-83.

Alberti A, Pirrone P, Elia M, Waring RH, Romano C. Sulphation deficit in “low functioning” autistic children: a pilot study. Biol Psychiatry1999;46(3):420-4.

Rossignol DA, Frye RE. Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism. Front Physiol (2014) 5:150. doi:10.3389/fphys.2014.00150

Napoli E, Wong S, Hertz-Picciotto I, Giulivi C. Deficits in bioenergetics and impaired immune response in granulocytes from children with autism. Pediatrics (2014) 133:e1405–10. doi:10.1542/peds.2013-1545

Giulivi C, Zhang YF, Omanska-Klusek A, et al. Mitochondrial dysfunction in autism. JAMA. 2010;304(21): 2389-96.

Rossignol DA, Bradstreet JJ. Evidence of mitochondrial dysfunction in autism and implications for treatment. Am J Biochem Biotechnology. 2008;4(2):208-17.

Celestino-Soper PB, Violante S, Crawford EL, et al. A common X-linked inborn error of carnitine biosynthesis may be a risk factor for nondysmorphic autism. Proc Natl Acad Sci U S A. 2012:109(21): 7974-81.

Anitha A, Nakamura K, Thanseem I, Matsuzaki H, Miyachi T, Tsujii M, et al. Downregulation of the expression of mitochondrial electron transport complex genes in autism brains. Brain Pathol (2013) 23:294–302. doi:10.1111/bpa. 12002

Tang G, Gutierrez Rios P, Kuo SH, Akman HO, Rosoklija G, Tanji K, et al. Mitochondrial abnormalities in temporal lobe of autistic brain. Neurobiol Dis (2013) 54:349–61. doi:10.1016/j.nbd.2013.01.006

Gvozdjakova A, Kucharska J, Ostatnikova D, Babinska K, Nakladal D, Crane FL. Ubiquinol improves symptoms in children with autism. Oxid Med Cell Longev (2014) 2014:798957. doi:10.1155/2014/798957

Rose S, Frye RE, Slattery J, Wynne R, Tippett M, Melnyk S, et al. Oxidative stress induces mitochondrial dysfunction in a subset of autistic lymphoblastoid cell lines. Transl Psychiatry (2014) 4:e377. doi:10.1038/ tp.2014.15

Lau NM, Green PH, Taylor AK, et al. Markers of celiac disease and gluten sensitivity in children with autism. PLoS One. 2013 Jun 18;8(6):e66155.

D‘Eufemia P, Celli M, Finocchiaro R, et al. Abnormal intestinal permeability in children with autism. Acta Paediatr. 1996;85(9):1076-9.

Reichelt KL, Tveiten D, Knivsberg AM, Brønstad G. Peptides’ role in autism with emphasis on exorphins. Microb Ecol Health Dis. 2012;23: 10.3402/ mehd.v23i0.18958.

Reichelt KL, Knivsberg AM. Can the pathophysiology of autism be explained by the nature of the discovered urine peptides? Nutr Neurosci. 2003;6(1):19-28.

Reichelt KL, Knivsberg AM. The possibility and probability of a gut-to-brain connection in autism. Ann Clin Psychiatry. 2009;21(4):205-11.

Whiteley P, Haracopos D, Knivsberg AM, et al. The ScanBrit randomised, controlled, single-blind study of a gluten-free and casein-free dietary intervention for children with autism spectrum disorders. Nutr Neurosci. 2010;13(2):87-100.

Whiteley P, Shattock P, Knivsberg AM, et al. Gluten- and casein-free dietary interventions for autism spectrum conditions. Front Hum Neurosci. 2013 Jan 4;6:344.

Kang DW, Park JG, Ilhan ZE, et al. Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One. 2013;8(7):e68322.

Finegold SM, Molitoris D, Song Y, et al. Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis. 2002 Sep 1;35(Suppl 1):S6-16.

Finegold SM, Dowd SE, Gontcharova V, et al. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe. 2010;16(4):444-53.

Finegold SM. State of the art; microbiology in health and disease. Intestinal bacterial flora in autism. Anaerobe. 2011;17(6):367-8.

Shultz SR, MacFabe DF, Ossenkopp KP, et al. Intracerebroventricular injection of propionic acid, an enteric bacterial metabolic end-product, impairs social behavior in the rat: implications for an animal model of autism. Neuropharmacology. 2008;54(6):901-11.

Shultz SR, Macfabe DF, Martin S, et al. Intracerebroventricular injections of the enteric bacterial metabolic product proprionic acid impair cognition and sensorimotor ability in the Long-Evans rat: further development of a rodent model of autism. Behav Brain Res. 2009;200(1):33-41.

Schwab MA, Sauer SW, Okun JG, et al. Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial tox- ins. Biochem J. 2006;398(1):107-112.

Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol. 2005;57(1):67-81.

Pardo CA, Vargas DL, Zimmerman AW. Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry. 2005;17(6):485-95.

Rossignol DA, Genuis SJ, Frye RE. Environmental toxicants and autism spectrum disorders: a systematic review. Transl Psychiatry (2014) 4:e360. doi:10.1038/tp.2014.4

Rodriguez JI, Kern JK. Evidence of microglial activation in autism and its possible role in brain underconnectivity. Neuron Glia Biol. 2011;7(2-4):205- 213.

Pessah IN, Seegal RF, Lein PJ, et al. Immunologic and neurodevelopmental susceptibilities of autism. Neurotoxicology. 2008;29(3):532-545.

Onore C, Careaga M, Ashwood P. The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun. 2012;26(3):383-92.

Molloy CA, Morrow AL, Meinzen-Derr J, et al. Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunol. 2006;172(1- 2):198-205.

Li X, Chauhan A, Sheikh AM, et al. Elevated immune response in the brain of autistic patients. J Neuroimmunol. 2009;207(1-2); 111-6.

Vojdani A, Mumper E, Granpeesheh D, et al. Low natural killer cell cytotoxic activity in autism: the role of glutathione, IL-2 and IL-15. J Neuroimmunol. 2008;205(1-2):145-54.

Heuer L, Ashwood P, Schauer J, et al. Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms. Autism Res. 2008;1(5):275-83.

Singh VK. Phenotypic expression of autoimmune autistic disorder (AAD): a major subset of autism. Ann Clin Psychiatry. 2009;21(3):148-61.

Singer HS, Morris CM, Williams PN, Yoon DY, Hong JJ, Zimmerman AW. Antibrain antibodies in children with autism and their unaffected siblings. J Neuroimmunol. 2006;178(1-2):149-55.

Cabanlit M, Wills S, Goines P, Ashwood P, Van de Water J. Brain-specific auto- antibodies in the plasma of subjects with autistic spectrum disorder. Ann N Y Acad Sci. 2007;1107:92-103.

Domes G, Heinrichs M, Kumbier E, Grossmann A, Hauenstein K, Herpertz SC. Effects of intranasal oxytocin on the neural basis of face processing in autism spectrum disorder. Biol Psychiatry. 2013;74(3): 164-71.

Owen SF, Tuncdemir SN, Bader PL, Tirko NN, Fishell G, Tsien RW. Oxytocin enhances hippocampal spike transmission by modulating fast-spiking inter- neurons. Nature. 2013;500(7463):458-62.